Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
13 July 2018 Photo Johan Roux
Sikhululekile Luwaca named 100 Young Mandelas of the future
Sikhululekile Luwaca was recently named as one of 100 Young Mandelas of the future by News24 for his embodiment of Nelson Mandela’s characteristics.
On Tuesday 3 July 2018, News24.com announced the 100 Young Mandelas of the future. Among those nominated was Sikhululekile Luwaca, a former president of the Student Representative Council (SRC) at the University of the Free State (UFS).
 
“It is humbling. I embrace collective action and it would be unfair not to appreciate all the great minds I have encountered over the years and had the privilege to work with. Our individual progress can never be separated from that of the community. It is no longer I that lives, but us, we,” said Luwaca.

Six million readers nominated 1 000 South Africans from all walks of life who could be considered Mandelas of the future. Luwaca emerged in the Visionary category as one of the 100 who made the cut. The initiative was inspired by what would have been Nelson Mandela’s 100th birthday on 18 July 2018. “News24 set out to honour 100 young South Africans who embody the characteristics Mandela was best known for,” said a statement by News24.

While he was the SRC president, Luwaca’s office played a critical role in raising R1.2 million for underprivileged students. He continues to make major strides as the current chairperson of the UFS African National Congress Youth League (ANCYL). 

His social and political influence goes back to when a 13-year-old Luwaca founded an association that sought to address school dropouts in rural areas. In high school, the young philanthropist established an organisation that collected and distributed food for needy elders of Cathcart township in the Eastern Cape. For five years Luwaca served the Student Christian Organisation as chairperson. In 2013, he co-founded the Ubuntu School Project that donated 100 full school uniforms to Phomolong High School learners in Tembisa.

Later on as a UFS student, Luwaca helped found the Hand2Hand Student Association which drives fundraising initiatives, as well as the collection of non-perishable food items and second-hand textbooks for disadvantaged students. In 2015 he was elected a Residence Committee representative for House Outeniqua and SRC: Dialogue and Association. 

Luwaca was instrumental in facilitating a series of dialogues on transformation such as the Fees Must Fall movement and the Shimla Park incident.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept